Lung Cancer

A research comparison of two FDA-approved drugs in combination versus one FDA-approved drug in patients with advanced non-small cell lung cancer who have received one prior chemotherapy. Volunteers who have confirmed advanced non-small cell lung carcinoma (NSCLC) and have received one prior chemotherapy for metastatic NSCLC may be eligible. Research sites located throughout the United States.

More information

Please see http://www.centerwatch.com/patient/studies/cat34.html